Very High–Risk Primary Prostate Cancer Identified by p53 Immunohistochemistry
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-up
Eur Urol Oncol 2021 Dec 27;[EPub Ahead of Print], KH Stopsack, DC Salles, JB Vaselkiv, ST Grob, LA Mucci, TL LotanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.